Neurology

Amneal Launches Brekiya® – the First and Only DHE Autoinjector for Adults with Migraine With or Without Aura and Cluster Headaches

Brekiya® autoinjector, a new specialty therapy from Amneal, is now available for prescription exclusively through Walgreens Specialty Pharmacy and Sterling…

1 month ago

Evotec Announces Progress in Preclinical Neuroscience Partnership with Bristol Myers Squibb

Advances made in preclinical pipeline addressing neurodegenerative diseasesEvotec receives US$ 25 m payment to support continued progression of joint programs…

1 month ago

ANI Pharmaceuticals to Discuss Third Quarter 2025 Financial Results on November 7, 2025, at 8:30 a.m. ET

PRINCETON, N.J., Oct. 24, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that…

1 month ago

Medical Device Market Surges to USD 750 Billion by 2033, Propelled by 5.5% CAGR – Verified Market Reports®

The Medical Device Market is witnessing robust expansion driven by rising healthcare expenditure, growing prevalence of chronic diseases, and accelerating…

1 month ago

Dewpoint Therapeutics Announces an Open IND for First-in-Class Condensate Modulator DPTX3186 for Wnt-Driven Cancers

IND opening marks culmination of partnership between Dewpoint and Evotec, advancing a de novo development candidate through IND-enabling studiesFirst patient…

2 months ago

Medical Specialists of the Palm Beaches Unveils State-of-the-Art Medical Facility in Wellington, Florida

WELLINGTON, Fla., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Medical Specialists of the Palm Beaches (MSPB), a primary care-focused, multi-specialty physician…

2 months ago

Nxera’s Partner Cancer Research UK Presents Data from Successfully Completed Phase 1 Clinical Trial of Cancer Immunotherapy Drug HTL0039732 at ESMO

HTL0039732 (also known as NXE0039732) is Nxera’s novel oral EP4 antagonist with the potential to treat a wide range of…

2 months ago

From Signals to Strategy: The Next Chapter of Digital Biomarkers, Upcoming Webinar Hosted by Xtalks

In this free webinar, gain a strategic lens for building durable, scalable digital biomarker programs that deliver clinical and business…

2 months ago

PAJUNK® Expands U.S. Headquarters in Alpharetta, Georgia

Facility Growth Adds 30,000 Square Feet to Strengthen Warehouse, Cleanroom Production, and Office Capabilities ALPHARETTA, Ga., Oct. 16, 2025 /PRNewswire/…

2 months ago

Women are more vulnerable to brain diseases – New UCLA research explains why and points to promising treatment

LOS ANGELES, Oct. 15, 2025 /PRNewswire/ -- Women are twice as likely as men to develop Alzheimer's disease (AD) and multiple…

2 months ago